Tirzepatide Reconstitution Calculator
A dual GIP/GLP-1 receptor agonist of significant interest in metabolic peptide research. This page works out concentration, volume per measured amount, syringe units and preparations per vial for a reconstituted Tirzepatide preparation, plus the mass-to-molar conversions for its stated molecular weight. Everything runs in your browser; plan entries stay in this browser, with optional device-local saving and calendar export.
Also referenced as: LY3298176
02 / Calculated draw
Arithmetic from your entries. Confirm the product, concentration and syringe with your pharmacist or clinician before administration.
- Concentration
- —
- Amount per administration
- —
- Volume per administration
- —
- U-100 syringe marking
- —
- Whole administrations per vial
- —
- Remainder per vial
- —
Enter the vial, water and administration amounts to calculate.
Syringe capacity
Whole administrations exclude dead space, handling losses and expiry. A calculated quantity is not a guarantee of usable supply. No rounding to a nearby syringe mark is performed.
Protocol schedule
Schedule an existing prescribed or approved protocol. This tool cannot determine how often you can safely take a peptide. Frequency, dose, reconstitution, storage and discard instructions must come from the product label and your clinician or pharmacist.
04 / Your calendar
Complete your calculation and timing to build a schedule.
Calculations stay in this browser. Saving is optional and device-local. Calendar export creates a file; import it into your calendar and configure reminders there. PeptiDex does not send notifications.
| Date & time | Amount | Draw | Vial |
|---|
Measurement reference: FDA guidance on concentration, syringe size and mg/mL/unit conversion errors.
A separate worked example, step by step
This separate arithmetic example uses a 5 mg vial, 2 mL of bacteriostatic water, and a 250 mcg target amount. They are not a property of Tirzepatide and not an amount anyone should draw — these figures only illustrate the arithmetic.
- Concentration. 5 mg ÷ 2 mL = 2.5 mg/mL (2,500 mcg/mL), which for Tirzepatide is approximately 0.5194 mM at its stated molecular weight.
- Per syringe unit. A U-100 syringe divides 1 mL into 100 units, so one unit holds 2,500 mcg ÷ 100 = 25 mcg.
- Volume for the 250 mcg target. 250 mcg ÷ 2,500 mcg/mL = 0.1 mL, or 10 units on that syringe.
- Preparations per vial. 5,000 mcg ÷ 250 mcg = 20 preparations.
Arithmetic on a laboratory preparation, shown as a unit-conversion reference. Not medical advice, not a dosing recommendation, not an instruction for human use. The full derivation, and why the diluent volume is a choice rather than a constant, is on the main reconstitution calculator.
Mass and molar equivalents for Tirzepatide
Derived from the molecular weight recorded on the Tirzepatide entry: 4813.5 g/mol. Concentration in molar units is what an in-vitro protocol is usually specified in.
| Quantity | Molar equivalent |
|---|---|
| 1 mg of Tirzepatide | 207.7 nmol (0.2077 µmol) |
| 1 mcg of Tirzepatide | 0.2077 nmol |
| A 1 mg/mL solution | 0.2077 mM (207.7 µM) |
Molar amount = mass ÷ molecular weight. Figures are shown to four significant digits and are a unit conversion, not a measurement.
Reconstitution recorded for Tirzepatide
Lyophilized powder typically reconstituted with bacteriostatic water; refrigerate and protect from light after reconstitution.
Quoted from the Tirzepatide entry. Amounts reported in the research literature for this compound are documented on that entry, under the disclaimer they belong with — they are not reproduced next to a calculator. Read the full Tirzepatide entry.
Handling questions for Tirzepatide
What purity and documentation should be expected for research-grade tirzepatide?
A third-party COA with HPLC purity (commonly greater than or equal to 98%) and mass-spec identity confirmation is the standard reference documentation. Lyophilized peptide should be stored cold and reconstituted with bacteriostatic water for research handling, protected from light and freeze-thaw cycles.
Answers are published on the Tirzepatide entry. Educational summaries of research-literature context, not medical advice.
Continue exploring
- Full Tirzepatide entry — Dual GIP/GLP-1 receptor agonist
- Reconstitution calculator — the maths in full, with a second worked example
- Storage & Handling guide
- Bacteriostatic water — what it is and how it differs from sterile water
- Compare Tirzepatide with another library entry